PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, 68100, Alexandroupolis, Greece.\', \'Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, 68100, Alexandroupolis, Greece. emanolop@med.duth.gr.\', \'Clinical Pharmacology and Pharmacogenetics Unit, Academic General Hospital of Alexandroupolis, Alexandroupolis, Greece. emanolop@med.duth.gr.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00228-020-02963-4
?:doi
?:hasPublicationType
?:journal
  • European journal of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32696234
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.159
?:rankingScore_hIndex
  • 96
is ?:relation_isRelatedTo_publication of
?:title
  • Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32696234>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32696234>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all